Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
669642
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly conversion and exercise status of the 3rd unsecured convertible bond-type bonds with stock acquisition rights and the 8th stock acquisition rights issued through a third-party allotment
Intended allottee
EVO FUND (allottee for the issuance on 1 June 2026)
発行済株式総数
1.7% (ratio relating to the conversion and exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
For the 8th stock acquisition rights, exercise prices ranging from ¥82.0 to ¥70.0 during the reporting month are stated. Subject to an exercise price adjustment provision. Floor Not disclosed. For the 3rd convertible bond-type bonds with stock acquisition rights, conversion prices ranging from ¥73.8 to ¥63.0 are stated. Subject to a conversion price adjustment provision. Floor Not disclosed.
Number of Stock Acquisition Rights
8th stock acquisition rights: 100,000 issued, 0 exercised during the reporting month, and 99,000 unexercised at month-end (9,900,000 shares)
Payment date
1 June 2026 (stated as the issue date)
Procedures under the Corporate Code of Conduct
Describes compliance with the conversion and exercise restrictions under Article 434 of the Listing Regulations.
Most recent equity financing
Timing 1 June 2026 / Type New shares through a third-party allotment (contribution in kind (debt-equity swap)) / Amount Not disclosed, Timing 1 June 2026 / Type 3rd unsecured convertible bond-type bonds with stock acquisition rights (subject to a conversion price adjustment provision) / Amount Total issue amount: ¥300,000,000, Timing 1 June 2026 / Type 8th stock acquisition rights (subject to an exercise price adjustment provision) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly conversion and exercise status of the 3rd unsecured convertible bond-type bonds with stock acquisition rights and the 8th stock acquisition rights issued through a third-party allotment |
| Payment date | 1 June 2026 (stated as the issue date) |
| Intended allottee | EVO FUND (allottee for the issuance on 1 June 2026) |
| Dilution Rate | 1.7% (ratio relating to the conversion and exercise restrictions) |
| Total number of issued shares | 41,883,717 shares (as of the end of the month preceding the reporting month) → Not disclosed |
| Exercise price | For the 8th stock acquisition rights, exercise prices ranging from ¥82.0 to ¥70.0 during the reporting month are stated. Subject to an exercise price adjustment provision. Floor Not disclosed. For the 3rd convertible bond-type bonds with stock acquisition rights, conversion prices ranging from ¥73.8 to ¥63.0 are stated. Subject to a conversion price adjustment provision. Floor Not disclosed. |
| Number of Stock Acquisition Rights | 8th stock acquisition rights: 100,000 issued, 0 exercised during the reporting month, and 99,000 unexercised at month-end (9,900,000 shares) |
| Procedures under the Corporate Code of Conduct | Describes compliance with the conversion and exercise restrictions under Article 434 of the Listing Regulations. |
| Most recent equity financing | Timing 1 June 2026 / Type New shares through a third-party allotment (contribution in kind (debt-equity swap)) / Amount Not disclosed, Timing 1 June 2026 / Type 3rd unsecured convertible bond-type bonds with stock acquisition rights (subject to a conversion price adjustment provision) / Amount Total issue amount: ¥300,000,000, Timing 1 June 2026 / Type 8th stock acquisition rights (subject to an exercise price adjustment provision) / Amount Not disclosed |
Items this document does not state (19)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly conversion and exercise status for August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.